- Investor's Business Daily•2 days ago
Potential blockbuster combo drugs from Sanofi and Novo Nordisk are near launch, and reducing death rates may be next battleground.
- Market Realist•11 days ago
The European Medicines Agency’s CHMP gave positive recommendations to seven medicines for the extension of therapeutic indications in its June meeting.
Novo Nordisk A/SNYSE
After hours: 56.641.01 (1.82%) as of 5:16 PM EDT
|Bid||54.00 x 300|
|Ask||56.50 x 200|
|52wk Range||46.17 - 60.34|
|Day's Range||55.21 - 55.64|
|Avg Vol (3m)||1,341,779|
As of 4:01 PM EDT. Market closed.